Sodium Nitrite is the standout — a sole-source US RX cyanide antidote, exactly the specialty-injectable scarcity Juno hunts. Dobutamine HCl injection and Bloxiverz (neostigmine) are the next reads: both active US critical-care/anaesthesia injectables with thin recorded sales despite real clinical demand. Pyridostigmine injectable rounds out the shortlist as a myasthenia-gravis specialty injectable with few real suppliers. The Health Canada Cancelled-Post-Market entries (isoproterenol, procainamide caps, Dobutrex, Stimuline, Lanoxin pediatric) are largely filter noise — the registry is no longer live even if the molecules are still relevant.
The model — what Ianstein scored against
Check the model first.
Every candidate below was scored against this. If the model itself is wrong, or missing something Sophie weighs, that is the most important thing to tell us — correct it here.
SOPHIE'S LENS — hidden-sales / blue-ocean opportunity detection.
THE HUNT:
A hidden-sales opportunity is a product approved and on-market in a
territory's regulatory registry but showing little or no sales in the data.
The gap is the signal: low recorded sales on an approved product point to
inherent scarcity, few competitors, and a market others are not watching —
a blue ocean, where Juno prefers to play.
WHAT RAISES A CANDIDATE'S SCORE:
- Active registry status — not a long-discontinued molecule — a live market.
- A product type Juno can make or source: specialty injectables, generics,
biosimilars, OTC, medical devices, cardiovascular.
- A sign of genuine unmet need or supply scarcity — an essential drug that is
simply under-supplied, not an obsolete one.
- A core territory: Canada, US, UK, Australia.
- A plausible payback — a market worth re-entering.
WHAT LOWERS A SCORE / IS NOISE:
- A genuinely obsolete molecule with no remaining clinical need.
- Off Juno's product focus — pure oncology, ophthalmology, branded rare disease.
- An already heavily commoditised product with many competitors.
SCORING GUIDE (0-100 for opportunity fit):
80-100 active, on-focus, core territory, real scarcity and payback signal
55-79 matches some dimensions — worth a look
below 55 off-focus, obsolete or commoditised — the filter working
State plainly in the rationale which signals the candidate matched or missed.
Candidates · ranked by opportunity fit · check the logic on each
Held in — the vault, a local database: C:\Users\KevinFactor\Documents\Claude\Cpoint Capital\01-intelligence\ianstein-engine\data\ianstein.db Source files — cached under the engine's data/raw/ folder Sales data — placeholder, pending Sophie's IQVIA export Scored by — Claude Opus 4.7, against the model above